BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13285209)

  • 1. [The uterine cervix carcinoma in situ. II. Proliferation forms of the cervical epithelium; the concept of the invasive carcinoma; therapy of the carcinoma in situ, as seen from the pathologist's and gynecologist's standpoint; nomenclature].
    FEYRTER F
    Dtsch Med Wochenschr; 1955 Nov; 80(46):1686-91. PubMed ID: 13285209
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on probable or possible malignant cervical lesions-carcinoma in situ. I. Histology of carcinoma in situ. Nomenclature of the atypical epithelium.
    BAJARDI F; BICKENBACH W; SOOST HJ; de BRUX ; WENNER-MANGEN H
    Acta Cytol; 1961; 5():344-54. PubMed ID: 13686037
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium on probable or possible malignant cervical lesions - carcinoma in situ. I. Histology of carcinoma in situ. A study of basement membranes of normal epithelium, carcinoma in situ and invasive carcinoma of uterine cervix utilizing electron microscopy and histochemical methods.
    ASHWORTH CT; STEMBRIDGE VA; LUIBEL FJ
    Acta Cytol; 1961; 5():369-84. PubMed ID: 13684770
    [No Abstract]   [Full Text] [Related]  

  • 4. RECURRENCE AND THERAPEUTIC PROBLEMS IN CERVICAL DYSPLASIA AND IN SITU CANCER.
    MICHALKIEWICZ W; PRZYBORA LA; SIMM S; WOLNA M
    Cancer; 1963 Sep; 16():1212-21. PubMed ID: 14065083
    [No Abstract]   [Full Text] [Related]  

  • 5. Colpomicroscopy of anaplasia (dysplasia) and carcinoma in situ of the uterine cervix.
    OKAGAKI T; AUSTIN JH; YOUNGE PA
    Acta Cytol; 1962; 6():403-4. PubMed ID: 14481507
    [No Abstract]   [Full Text] [Related]  

  • 6. [The concept of cervical intraepithelial neoplasia].
    Dominok GW; Beckert W
    Z Arztl Fortbild (Jena); 1985; 79(22):949-51. PubMed ID: 4096008
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoma-in-situ and dysplasia of the cervix.
    GRAY LA; BARNES ML; LEE JJ
    Ann Surg; 1960 Jun; 151(6):951-60. PubMed ID: 13829114
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differences in the occurrence and changes in mast cells in cervix dysplasia and carcinoma in situ].
    Opacki W
    Ginekol Pol; 1986 Jan; 57(1):56-63. PubMed ID: 3721270
    [No Abstract]   [Full Text] [Related]  

  • 9. Symposium on probable or possible malignant cervical lesions-carcinoma in situ. I. Histology of carcinoma in situ. The atypical non-invasive zones around invasive cervical carcinoma.
    BAJARDI F; SIRTORI C
    Acta Cytol; 1961; 5():355-8. PubMed ID: 13686039
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surgery of the cervix, excluding invasive cancer and including especially gaping cervix, intraepithelial epithelioma and prolapses].
    BERTRAND P
    Bull Fed Soc Gynecol Obstet Lang Fr; 1961; 13():271-7. PubMed ID: 13868522
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of punch biopsy in the diagnosis of carcinoma in situ of the cervix uteri.
    THOMISON JB; TOSH RH
    Am J Obstet Gynecol; 1962 Jul; 84():98-100. PubMed ID: 13920850
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neural proliferation as a concomitant finding in neoplasias and benign ectopias of the uterine cervix].
    Bajardi F
    Zentralbl Gynakol; 1985; 107(4):227-36. PubMed ID: 3984574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistological demonstration of carcinoembryonic antigen in intra-epithelial and invasive squamous carcinoma of the cervix.
    McDicken IW; Rainey M
    Histopathology; 1983 Jul; 7(4):475-85. PubMed ID: 6350149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of cervical carcinoma in situ following aureomycin.
    AYRE JE
    South Med J; 1952 Oct; 45(10):915-21. PubMed ID: 13005076
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with the Oxford tumour marker in uterine cervical lesions.
    Beltrami CA; Di Loreto C; De Nictolis M; Stramazzotti D
    Appl Pathol; 1984; 2(1):39-42. PubMed ID: 6395880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symposium on probable or possible malignant cervical lesions-carcinoma in situ. I. Histology of carcinoma in situ. What is not carcinoma in situ?
    BAJARDI F; GAUDE FROY MG; KRIMMENAU R; TAYLOR CW
    Acta Cytol; 1961; 5():331-9. PubMed ID: 13686038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Accompanying histological changes in the cervix uteri in carcinoma in situ and early invasive carcinoma].
    Krizanac S; Jukić S; Bolanca M
    Lijec Vjesn; 1987; 109(11-12):418-21. PubMed ID: 3695790
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysplasia, carcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Christopherson WM
    Hum Pathol; 1977 Sep; 8(5):489-501. PubMed ID: 903142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIGNIFICANCE OF DIFFERENTIAL CELL COUNT OF SMEARS IN THE DIAGNOSIS OF CARCINOMA IN SITU AND ANAPLASIA (ATYPICAL HYPERPLASIA, DYSPLASIA) OF THE UTERINE CERVIX. I. FOUR COMPONENTS OF EXFOLIATED ABNORMAL CELLS IN SMEARS.
    OKAGAKI T
    J Jpn Obstet Gynecol Soc; 1964 Jan; 11():17-22. PubMed ID: 14197084
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphology and histogenesis of dysplasias of the cervix uteri].
    Iakovleva IA; ChernyÄ­ AP
    Arkh Patol; 1985; 47(11):32-7. PubMed ID: 4091694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.